FIELD: medicine. SUBSTANCE: invention relates to the use of agonist of cannabinoid receptors R-(+)-methanandamide as an anti-arrhythmic agent. EFFECT: enhanced effectiveness of treatment. 1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-ARRHYTHMIC AGENT | 2004 |
|
RU2260442C1 |
ANTI-ARRHYTHMIC AGENT | 2003 |
|
RU2235553C1 |
PREPARATION FOR TREATING ARRHYTHMIA | 1998 |
|
RU2163807C2 |
ANTI-ARRHYTHMIC AGENT | 2005 |
|
RU2320342C2 |
ANTIARRHYTHMIC AGENT | 1998 |
|
RU2171115C2 |
CARDIOTONIC PREPARATION | 1998 |
|
RU2163817C2 |
AGENT IMPROVING BLOOD SUPPLY AND MYOCARDIAL METABOLISM | 2002 |
|
RU2225201C2 |
AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS | 1999 |
|
RU2189173C2 |
THERAPEUTIC AGENT FOR TREATMENT OF DIFFERENT FORMS OF HEART RHYTHM DISTURBANCES | 2000 |
|
RU2180583C1 |
Authors
Dates
2002-12-27—Published
2001-04-09—Filed